Cited by

• Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand.

  Olsson MY, Kärre K, Sentman CL. Olsson MY, et al. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1649-53. doi: 10.1073/pnas.92.5.1649. Proc Natl Acad Sci U S A. 1995. PMID: 7878033 Free PMC article.
• Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.

  Nishimura M, Mitsunaga S, Akaza T, Mitomi Y, Tadokoro K, Juji T. Nishimura M, et al. Immunology. 1994 Sep;83(1):75-80. Immunology. 1994. PMID: 7821970 Free PMC article.
• Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

  Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Moretta A, et al. J Exp Med. 1995 Sep 1;182(3):875-84. doi: 10.1084/jem.182.3.875. J Exp Med. 1995. PMID: 7650491 Free PMC article.
• Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

  Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, Compans RW, von Andrian UH. Paust S, et al. Nat Immunol. 2010 Dec;11(12):1127-35. doi: 10.1038/ni.1953. Epub 2010 Oct 24. Nat Immunol. 2010. PMID: 20972432 Free PMC article.
• Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.

  Vitale M, Sivori S, Pende D, Moretta L, Moretta A. Vitale M, et al. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3536-40. doi: 10.1073/pnas.92.8.3536. Proc Natl Acad Sci U S A. 1995. PMID: 7724594 Free PMC article.